Home >> Research Area >>Natural Products>>Diterpenoids>> Dehydroandrographolidesuccinate

Dehydroandrographolidesuccinate

CAS# 786593-06-4

Dehydroandrographolidesuccinate

Catalog No. BCN8359----Order now to get a substantial discount!

Product Name & Size Price Stock
Dehydroandrographolidesuccinate: 5mg Please Inquire In Stock
Dehydroandrographolidesuccinate: 10mg Please Inquire In Stock
Dehydroandrographolidesuccinate: 20mg Please Inquire Please Inquire
Dehydroandrographolidesuccinate: 50mg Please Inquire Please Inquire
Dehydroandrographolidesuccinate: 100mg Please Inquire Please Inquire
Dehydroandrographolidesuccinate: 200mg Please Inquire Please Inquire
Dehydroandrographolidesuccinate: 500mg Please Inquire Please Inquire
Dehydroandrographolidesuccinate: 1000mg Please Inquire Please Inquire

Quality Control of Dehydroandrographolidesuccinate

Number of papers citing our products

Chemical structure

Dehydroandrographolidesuccinate

3D structure

Chemical Properties of Dehydroandrographolidesuccinate

Cas No. 786593-06-4 SDF Download SDF
PubChem ID 6540717 Appearance White crystalline powder
Formula C28H36O10 M.Wt 532.582
Type of Compound Diterpenoids Storage Desiccate at -20°C
Solubility DMSO : 250 mg/mL (469.41 mM; Need ultrasonic)
Chemical Name 4-[[(1R,2R,4aR,5R,8aS)-2-(3-carboxypropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoic acid
SMILES CC12CCC(C(C1CCC(=C)C2C=CC3=CCOC3=O)(C)COC(=O)CCC(=O)O)OC(=O)CCC(=O)O
Standard InChIKey YTHKMAIVPFVDNU-GPTWTFMPSA-N
Standard InChI InChI=1S/C28H36O10/c1-17-4-7-20-27(2,19(17)6-5-18-13-15-36-26(18)35)14-12-21(38-25(34)11-9-23(31)32)28(20,3)16-37-24(33)10-8-22(29)30/h5-6,13,19-21H,1,4,7-12,14-16H2,2-3H3,(H,29,30)(H,31,32)/b6-5+/t19-,20+,21-,27+,28+/m1/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Dehydroandrographolidesuccinate

The herbs of Andrographis paniculata

Biological Activity of Dehydroandrographolidesuccinate

DescriptionDehydroandrographolide succinate can alleviate oxidative stress in LPS-induced acute lung injury possibly by inactivating iNOS. It combined with ribavirin treatedchildren with hand-foodand mouth disease,the duration of fever was shorter,rashes on hands and feet more quickyly.
TargetsNOS | TNF-α | IL recepter | SOD | Antifection
In vivo

Therapeutic effects of dehydroandrographolide succinate combined with ribavirin on children with hand-foot-and-mouth disease[Reference: WebLink]

Anhui Medical Journal, 2010.

To evaluate the therapeutic effects of Dehydroandrographolide succinate and ribavirin on children with the early severe tendencies of hand-foot-and-mouth disease.
METHODS AND RESULTS:
Children(46 cases) with the early tendencies of hand-foot-and-mouth disease were divided randomly into two groups.All cases received ribavirin and therapies based on their symptoms,while the treatment group of 23 children received Dehydroandrographolide succinate(10 mg.kg-1.d-1) for 5 days.Clinical symptom regression time or recovery time in two groups were observed after treatments. All children were recovered after treatments and no case develop into neurogenic pulmonary edema or cardiopulmonary collapse.The duration of fever was shorter in the treatment group;rashes on hands and feet faded more quickly than those of the control group.The difference between the two groups had statistical significance.However,there was no statistically significant differences between the two groups as for the time of mental improvement,disappearance of body shaking and hospital stay time.
CONCLUSIONS:
Dehydroandrographolide succinate combined with ribavirin treatedchildren with hand-foodand mouth disease,the duration of fever was shorter,rashes on hands and feet more quickyly.

Protocol of Dehydroandrographolidesuccinate

Animal Research

Dehydroandrographolide succinate inhibits oxidative stress in mice with lipopolysaccharide-induced acute lung injury by inactivating iNOS.[Pubmed: 22985554]

Nan Fang Yi Ke Da Xue Xue Bao. 2012 Sep;32(9):1238-41.

To investigate the effect of Dehydroandrographolide succinate (DAS) on oxidative stress and induced nitric oxide synthase (iNOS) expression in a mouse model of lipopolysaccharide (LPS)-induced acute lung injury.
METHODS AND RESULTS:
Thirty male BALB/C mice were randomly divided into control group, LPS+DAS group and LPS group (n=10). The levels of interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), malondialdehyde (MDA) and superoxide dismutase (SOD) in the bronchoalveolar lavage fluid (BALF) were measured. The wet-to-dry ratio (W/D) of the lung tissue was determined to evaluate lung edema. HE staining was used to observe the pathological changes and lung injury scores. The expressions of iNOS mRNA and protein in the lungs were analyzed using RT-PCR and Western blotting, respectively. IL-1β, IL-6, TNF-α and MDA levels in the BALF, W/D, lung injury scores, and iNOS mRNA and protein expressions increased and SOD in the BALF decreased significantly after intratracheal LPS injection. Compared with those in LPS group, IL-1β, IL-6, TNF-α and MDA in BALF, W/D, lung injury scores and iNOS mRNA and protein expression were significantly reduced and SOD in the BALF significantly increased in LPS+DAS group.
CONCLUSIONS:
Dehydroandrographolide succinate can alleviate oxidative stress in LPS-induced acute lung injury possibly by inactivating iNOS.

Dehydroandrographolidesuccinate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Dehydroandrographolidesuccinate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Dehydroandrographolidesuccinate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.8776 mL 9.3882 mL 18.7765 mL 37.5529 mL 46.9411 mL
5 mM 0.3755 mL 1.8776 mL 3.7553 mL 7.5106 mL 9.3882 mL
10 mM 0.1878 mL 0.9388 mL 1.8776 mL 3.7553 mL 4.6941 mL
50 mM 0.0376 mL 0.1878 mL 0.3755 mL 0.7511 mL 0.9388 mL
100 mM 0.0188 mL 0.0939 mL 0.1878 mL 0.3755 mL 0.4694 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

Description

Dehydroandrographolide succinate, extracted from herbal medicine Andrographis paniculata (Burm f) Nees, is widely used for the treatment of viral pneumonia and viral upper respiratory tract infections because of its immunostimulatory, anti-infective and anti-inflammatory effect.

Keywords:

Dehydroandrographolidesuccinate,786593-06-4,Natural Products, buy Dehydroandrographolidesuccinate , Dehydroandrographolidesuccinate supplier , purchase Dehydroandrographolidesuccinate , Dehydroandrographolidesuccinate cost , Dehydroandrographolidesuccinate manufacturer , order Dehydroandrographolidesuccinate , high purity Dehydroandrographolidesuccinate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: